Update shared on 28 Nov 2025
Proximus Global + Starlink: Direct-to-Cell Push Sends Shares Up 6%
- Partnership: Proximus Global partners with Starlink via BICS as Europe’s preferred IPX provider.
- Service Launch: Enables direct-to-cell satellite connectivity, starting with Kyivstar in Ukraine.
- Market Impact; Proximus shares jumped 6% on Euronext Brussels.
- Strategic Vision: Expands coverage where terrestrial networks are limited and strengthens leadership in combining terrestrial and satellite networks alongside AI and 6G initiatives, hinting at potential long-term value for investors.
Related News: Proximus Global + Starlink to expand Direct-to-Cell connectivity in Europe.
Articles:
- What’s up with… Deutsche Telekom, Proximus, Bouygues Telecom, Veon TelecomTV Staff.
- Proximus Global + Starlink to expand Direct-to-Cell satellite connectivity in
- EuropeStarlink taps Proximus Global to power Europe-wide direct-to-cell connectivity
"This is not financial advice. All views expressed are personal interpretations of publicly available information and are not predictions or recommendations."
Disclaimer
The user RecMag has a position in ENXTBR:PROX. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.